One In 10 European Schools Lack Basic Hand-Washing Facilities – Adding To COVID-19 Risks As Schools Reopen 21/07/2020 Svĕt Lustig Vijay In past decades, Europe has achieved one of the world’s highest water and sanitation coverages, but it is often forgotten that one in ten schools in the 53 countries of WHO’s European region still lack basic hand washing facilities, leaving some 5 million pupils without access to soap and clean water. All in all, some 31 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice On Masks Still Falls Short 10/07/2020 Svĕt Lustig Vijay Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice On Masks Still Falls Short 10/07/2020 Svĕt Lustig Vijay Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice On Masks Still Falls Short 10/07/2020 Svĕt Lustig Vijay Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice On Masks Still Falls Short 10/07/2020 Svĕt Lustig Vijay Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice On Masks Still Falls Short 10/07/2020 Svĕt Lustig Vijay Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice On Masks Still Falls Short 10/07/2020 Svĕt Lustig Vijay Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice On Masks Still Falls Short 10/07/2020 Svĕt Lustig Vijay Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Concedes Airborne Transmission of SARS-CoV-2; Critics Say Advice On Masks Still Falls Short 10/07/2020 Svĕt Lustig Vijay Just three days after almost 240 scientists criticized WHO for downplaying the risks of airborne transmission of tiny SARS-CoV-2 particles, or aerosols, the Organization edged closer to its critics point of view. WHO’s latest scientific brief, published Thursday, acknowledges that “short-range aerosol transmission cannot be ruled out”. The tiny virus particles floating through the air […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Posts navigation Older postsNewer posts